Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Percutaneous Recanalization in Ischemic Stroke Management in Europe Observational Registry
- Conditions
- Ischemic Stroke
- First Posted Date
- 2012-03-22
- Last Posted Date
- 2012-04-05
- Lead Sponsor
- MindFrame, Inc.
- Target Recruit Count
- 1000
- Registration Number
- NCT01560247
Percutaneous Recanalization in Ischemic Stroke Management (PRIISM): A Feasibility Clinical Study
Phase 2
Completed
- Conditions
- Ischemic Stroke
- First Posted Date
- 2008-12-17
- Last Posted Date
- 2012-07-26
- Lead Sponsor
- MindFrame, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT00810095
- Locations
- 🇩🇪
University of Heidelberg, Heidelberg, Germany
News
No news found